Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Response criteria for essential thrombocythemia and polycythemia vera: result of a European LeukemiaNet consensus conference.

Barosi G, Birgegard G, Finazzi G, Griesshammer M, Harrison C, Hasselbalch HC, Kiladjian JJ, Lengfelder E, McMullin MF, Passamonti F, Reilly JT, Vannucchi AM, Barbui T.

Blood. 2009 May 14;113(20):4829-33. doi: 10.1182/blood-2008-09-176818. Epub 2009 Mar 10.

2.

Alpha-interferon in polycythemia vera and essential thrombocythemia.

Turri D, Mitra ME, Di Trapani R, Lipari MG, Perricone R, Cajozzo A.

Haematologica. 1991 Jan-Feb;76(1):75-7.

PMID:
2055565
3.

Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia.

Murphy S.

Semin Hematol. 1999 Jan;36(1 Suppl 2):9-13. Review.

PMID:
9930551
5.

The rate of progression to polycythemia vera or essential thrombocythemia in patients with erythrocytosis or thrombocytosis.

Ruggeri M, Tosetto A, Frezzato M, Rodeghiero F.

Ann Intern Med. 2003 Sep 16;139(6):470-5.

PMID:
13679323
6.

Polycythaemia vera and essential thrombocythaemia: current treatment strategies.

Penninga EI, Bjerrum OW.

Drugs. 2006;66(17):2173-87. Review.

PMID:
17137402
7.

WHO bone marrow features and European clinical, molecular, and pathological (ECMP) criteria for the diagnosis of myeloproliferative disorders.

Michiels JJ, De Raeve H, Hebeda K, Lam KH, Berneman Z, Schroyens W, Schwarz J.

Leuk Res. 2007 Aug;31(8):1031-8. Epub 2007 Mar 23. Review.

PMID:
17367853
8.

Essential thrombocythemia following polycythemia vera: an unusual sequence.

Randi ML, Barbone E, Zerbinati P, Soini B, Rossi C, Girolami A.

J Med. 1996;27(5-6):363-8.

PMID:
9151204
9.

Response criteria for myelofibrosis with myeloid metaplasia: results of an initiative of the European Myelofibrosis Network (EUMNET).

Barosi G, Bordessoule D, Briere J, Cervantes F, Demory JL, Dupriez B, Gisslinger H, Griesshammer M, Hasselbalch H, Kusec R, Le Bousse-Kerdiles MC, Liberato NL, Marchetti M, Reilly JT, Thiele J; European Myelofibrosis Network.

Blood. 2005 Oct 15;106(8):2849-53. Epub 2005 Jun 30.

10.

20+ yr without leukemic or fibrotic transformation in essential thrombocythemia or polycythemia vera: predictors at diagnosis.

Tefferi A, Gangat N, Wolanskyj AP, Schwager S, Pardanani A, Lasho TL, Mesa R, McClure RF, Li CY, Hanson CA.

Eur J Haematol. 2008 May;80(5):386-90. doi: 10.1111/j.1600-0609.2008.01038.x. Epub 2008 Jan 23.

PMID:
18221390
11.

Essential thrombocythemia/polycythemia vera and pregnancy: the need for an observational study in Europe.

Griesshammer M, Struve S, Harrison CM.

Semin Thromb Hemost. 2006 Jun;32(4 Pt 2):422-9. Review.

PMID:
16810618
12.
13.

Hydroxyurea in essential thrombocythemia: rate and clinical relevance of responses by European LeukemiaNet criteria.

Carobbio A, Finazzi G, Antonioli E, Vannucchi AM, Barosi G, Ruggeri M, Rodeghiero F, Delaini F, Rambaldi A, Barbui T.

Blood. 2010 Aug 19;116(7):1051-5. doi: 10.1182/blood-2010-03-272179. Epub 2010 May 17.

14.
15.

Differentiation between essential thrombocythemia and polycythemia vera with marked thrombocytosis.

Iland HJ, Laszlo J, Case DC Jr, Murphy S, Reichert TA, Tso CY, Wasserman LR.

Am J Hematol. 1987 Jun;25(2):191-201.

PMID:
3605067
17.

Assessment and prognostic value of the European LeukemiaNet criteria for clinicohematologic response, resistance, and intolerance to hydroxyurea in polycythemia vera.

Alvarez-Larrán A, Pereira A, Cervantes F, Arellano-Rodrigo E, Hernández-Boluda JC, Ferrer-Marín F, Angona A, Gómez M, Muiña B, Guillén H, Teruel A, Bellosillo B, Burgaleta C, Vicente V, Besses C.

Blood. 2012 Feb 9;119(6):1363-9. doi: 10.1182/blood-2011-10-387787. Epub 2011 Dec 12.

18.
19.

Revised response criteria for polycythemia vera and essential thrombocythemia: an ELN and IWG-MRT consensus project.

Barosi G, Mesa R, Finazzi G, Harrison C, Kiladjian JJ, Lengfelder E, McMullin MF, Passamonti F, Vannucchi AM, Besses C, Gisslinger H, Samuelsson J, Verstovsek S, Hoffman R, Pardanani A, Cervantes F, Tefferi A, Barbui T.

Blood. 2013 Jun 6;121(23):4778-81. doi: 10.1182/blood-2013-01-478891. Epub 2013 Apr 16.

20.

Should a platelet limit of 600 x 10(9)/l be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stages.

Lengfelder E, Hochhaus A, Kronawitter U, Höche D, Queisser W, Jahn-Eder M, Burkhardt R, Reiter A, Ansari H, Hehlmann R.

Br J Haematol. 1998 Jan;100(1):15-23.

PMID:
9450785

Supplemental Content

Support Center